| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Feb 24 | JSPR Jasper Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 17.95 | 40,000 | 718.00 k | 40,000 |
| 22 Sep 23 | JSPR Jasper Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 0.78 | 550,000 | 429.00 k | 550,000 |
| 23 Aug 23 | APGN Apexigen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.65 | 100,000 | 265.00 k | 0 |
| 23 Aug 23 | APGN Apexigen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.94 | 34,084 | 236.54 k | 0 |
| 2 Aug 23 | BCEL Atreca Inc - Ordinary Shares | Class A Common Stock | Sell | Dispose S | No | No | 0.9522 | 5,487 | 5.22 k | 72,817 |
